Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A | Index B | Index C | Index D | Index E | Index F | Index G | Index H | Index I | Index J | Index K | Index L | Index M | Index N | Index O | Index P | Index Q | Index R | Index S | Index T | Index U | Index V | Index W | Index X | Index Y | Index Z
grey line
 

Index S

Sadness: Sec. 4, Ch. 61
Safety
for fall prevention: Sec. 2, Ch. 11
home: (see also Home, safety of)
Saliva: Sec. 3, Ch. 39
production of: Sec. 1, Ch. 2
     aging-related changes in: Sec. 3, Ch. 54
     drug-assisted: Sec. 3, Ch. 39
Salivary glands
blockage of: Sec. 3, Ch. 39; Sec. 3, Ch. 39
Salmeterol: Sec. 3, Ch. 53; Sec. 3, Ch. 53
Salt (sodium chloride)
in fainting prevention: Sec. 3, Ch. 20
in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46
in hyperthermia prevention: Sec. 3, Ch. 19
Sarcopenia: Sec. 1, Ch. 2
Saw palmetto: Sec. 2, Ch. 7
in benign prostatic hyperplasia: Sec. 3, Ch. 59
drug interactions with: Sec. 2, Ch. 7
Scalp
seborrheic dermatitis of: Sec. 3, Ch. 35
Schatzki's ring: Sec. 3, Ch. 54
Sclera
color of: Sec. 1, Ch. 2
Sclerosis
aortic: Sec. 3, Ch. 48
Sclerotherapy: Sec. 3, Ch. 44
Scooter: Sec. 2, Ch. 13; Sec. 2, Ch. 13
Screening tests: Sec. 2, Ch. 10
cancer: Sec. 3, Ch. 50
     breast: Sec. 3, Ch. 50; Sec. 3, Ch. 51; Sec. 2, Ch. 10
     colorectal: Sec. 3, Ch. 50; Sec. 2, Ch. 10
     prostate: Sec. 3, Ch. 50; Sec. 3, Ch. 51; Sec. 2, Ch. 4
     skin: Sec. 3, Ch. 50
diabetes mellitus: Sec. 3, Ch. 34
hypothyroidism: Sec. 3, Ch. 33
nutrition: Sec. 2, Ch. 5
questionnaire for: Sec. 2, Ch. 10
recommendation for: Sec. 2, Ch. 10
Seasonal affective disorder: Sec. 3, Ch. 32; Sec. 3, Ch. 32
Seborrheic dermatitis: Sec. 3, Ch. 35
of vulva: Sec. 3, Ch. 58
Seborrheic wart: Sec. 3 Ch. 35 [sidebar]
Secobarbital: Sec. 2, Ch. 6
Sedatives: (see also Benzodiazepines)
in delirium: Sec. 3, Ch. 26
in dementia: Sec. 3, Ch. 27
medicinal herb interactions with: Sec. 2, Ch. 7
urinary incontinence with: Sec. 3, Ch. 57
Seizures
driving and: Sec. 4, Ch. 62
fainting with: Sec. 3 Ch. 20 [sidebar]
Selective estrogen receptor modifiers (SREMs): Sec. 3, Ch. 22; Sec. 3, Ch. 22
Selective serotonin reuptake inhibitors (SSRIs)
in anxiety: Sec. 3, Ch. 32
in depression: Sec. 3, Ch. 32
St. John's wort interaction with: Sec. 2, Ch. 7
undernutrition and: Sec. 3 Ch. 17 [detail]
Selegiline: Sec. 3, Ch. 30; Sec. 3, Ch. 30
Self-care activities: Sec. 1, Ch. 3
Self-determination: Sec. 4, Ch. 65
Self-image: Sec. 4, Ch. 63
Self-neglect: Sec. 4 Ch. 64 [sidebar]
Senescence: Sec. 1, Ch. 1
Senile plaques: Sec. 3, Ch. 27
Senior center: Sec. 2, Ch. 9
Senna: Sec. 3, Ch. 55; Sec. 3, Ch. 55
Sensation
dizzy: (see Dizziness; Fainting)
loss of
     in neuropathy: Sec. 3, Ch. 29
pain: Sec. 1, Ch. 2 (see also Pain)
Sensitivity
of test: Sec. 2, Ch. 10
Sensory nerves: Sec. 3, Ch. 29
Sepsis
with pressure sores: Sec. 3, Ch. 35
Septic arthritis: Sec. 3, Ch. 41
with pressure sores: Sec. 3, Ch. 35
SERMs (selective estrogen receptor modifiers): Sec. 3, Ch. 22
Sertraline
in depression: Sec. 3, Ch. 32
St. John's wort interaction with: Sec. 2, Ch. 7
undernutrition and: Sec. 3 Ch. 17 [detail]
Sex drive
in men: Sec. 1, Ch. 2
in women: Sec. 3, Ch. 58
Sex hormones: (see Estrogen; Testosterone)
Sex
oral: Sec. 4, Ch. 63
Sexual abuse: Sec. 4, Ch. 64
Sexual function
female: Sec. 3, Ch. 58
intimacy and: Sec. 4, Ch. 63
male: Sec. 3, Ch. 59
Sexually transmitted infection: Sec. 4, Ch. 63
Shock (electrical)
in cardioversion: Sec. 3, Ch. 47; Sec. 3, Ch. 47; Sec. 3, Ch. 47
in ventricular fibrillation: Sec. 3, Ch. 47
Shock (electroconvulsive) therapy: Sec. 3, Ch. 32
Shock wave therapy
in heel pain: Sec. 3, Ch. 40
Shock
cardiogenic: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
with hip fracture: Sec. 3, Ch. 23
Shoes
in arthritis: Sec. 3, Ch. 60
ill-fitting: Sec. 3, Ch. 40; Sec. 3, Ch. 40
proper fit of: Sec. 3, Ch. 40; Sec. 3, Ch. 40; Sec. 3, Ch. 40
Shortness of breath: (see Breath, shortness of)
Shoulder
fracture of: Sec. 3, Ch. 23
Shy-Drager syndrome: Sec. 3, Ch. 30
Sick sinus syndrome: Sec. 3, Ch. 47
Sigmoidoscopy
in constipation: Sec. 3, Ch. 55
Sildenafil
in erectile dysfunction: Sec. 3, Ch. 59
Silent ischemia: Sec. 3, Ch. 45
Simvastatin: Sec. 3, Ch. 44
in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45
Sinus (sinoatrial) node: Sec. 3, Ch. 47
Sinus bradycardia: Sec. 3, Ch. 47
Sinuses: Sec. 3, Ch. 38
Sinusitis: Sec. 3, Ch. 38
Sjögren's syndrome: Sec. 3, Ch. 36
dry mouth in: Sec. 3, Ch. 39
information resources on: 889
Skilled nursing facility: (see Nursing homes)
Skin graft
in pressure sores: Sec. 3, Ch. 35
in venous ulcers: Sec. 3, Ch. 35
Skin
aging of: Sec. 1, Ch. 2; Sec. 3, Ch. 35
biopsy of: Sec. 2, Ch. 10; Sec. 3, Ch. 35
blue color (cyanosis) of
     in heart failure: Sec. 3, Ch. 46
bumps on: Sec. 3 Ch. 35 [sidebar]
cancer of: Sec. 3 Ch. 35 [sidebar]; Sec. 3, Ch. 51
     information resources on: 884
     screening for: Sec. 3, Ch. 50; Sec. 3, Ch. 51
disorders of: Sec. 3, Ch. 35 (see also specific disorders)
dry: Sec. 3, Ch. 35
growths on: Sec. 3 Ch. 35 [sidebar]
itching of: Sec. 3, Ch. 35; Sec. 3, Ch. 35
rosacea of: Sec. 3, Ch. 35; Sec. 3, Ch. 35
seborrheic dermatitis of: Sec. 3, Ch. 35
spots on: Sec. 3 Ch. 35 [sidebar]
tags of: Sec. 3 Ch. 35 [sidebar]
thickened
     on feet: Sec. 3, Ch. 40
thinning of: Sec. 1, Ch. 2
ulcers of: Sec. 2, Ch. 11 (see also Pressure sores)
     with assistive devices: Sec. 2, Ch. 13
     in diabetes: Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3 Ch. 34 [sidebar]
     in dying person: Sec. 2, Ch. 16
undernutrition effects on: Sec. 3, Ch. 17
vulvar
     disorders of: Sec. 3, Ch. 58
Sleep aids: Sec. 3, Ch. 31
in dementia: Sec. 3, Ch. 27
valerian as: Sec. 2, Ch. 7
Sleep study: Sec. 3, Ch. 31; Sec. 2, Ch. 10
Sleep
aging-related changes in: Sec. 3, Ch. 31
apnea and: Sec. 3, Ch. 31
disorders of: Sec. 3, Ch. 31
     information resources on: 889
in Alzheimer's disease: Sec. 3, Ch. 27
in dementia: Sec. 3, Ch. 27; Sec. 3, Ch. 27; Sec. 3, Ch. 31
limb movement disorders of: Sec. 3, Ch. 31
NREM: Sec. 3 Ch. 31 [detail]
positive strategies for: Sec. 3, Ch. 31; Sec. 3 Ch. 31 [sidebar]
REM: Sec. 3 Ch. 31 [detail]
     thrashing during: Sec. 3, Ch. 31
Sleepiness
daytime: Sec. 3, Ch. 31; Sec. 3, Ch. 31
Sleepwalking: Sec. 3, Ch. 31
Sling: Sec. 3, Ch. 23
Small intestine
prolapse of (enterocele): Sec. 3, Ch. 58; Sec. 3, Ch. 58
Smell
aging-related changes in: Sec. 1, Ch. 2
impairment of: Sec. 3, Ch. 38
in Parkinson's disease: Sec. 3, Ch. 30
Smoking
acid reflux and: Sec. 3, Ch. 54
arrhythmias with: Sec. 3, Ch. 47
atherosclerosis and: Sec. 3, Ch. 44
COPD and: Sec. 3, Ch. 53
coronary artery disease and: Sec. 3, Ch. 45
lung cancer and: Sec. 3, Ch. 51
mouth cancer and: Sec. 3, Ch. 51
quitting (cessation) of
     in atherosclerosis: Sec. 3, Ch. 44
     in COPD: Sec. 3, Ch. 53
     in coronary artery disease: Sec. 3, Ch. 45
     in gastroesophageal reflux: Sec. 3, Ch. 54
     in stroke prevention: Sec. 3, Ch. 28
undernutrition and: Sec. 3 Ch. 17 [detail]
Social relationships: Sec. 4, Ch. 61; Sec. 4, Ch. 63
restrictions on: Sec. 4, Ch. 64
Social worker: Sec. 2, Ch. 9; Sec. 2, Ch. 9
at nursing home: Sec. 2, Ch. 14
Sodium channel blockers: Sec. 3, Ch. 47
Sodium
deficiency of: Sec. 3, Ch. 17
high levels of (hypernatremia): Sec. 3, Ch. 18
low levels of (hyponatremia): Sec. 3, Ch. 18
Sorbitol
in constipation: Sec. 3, Ch. 55
Sores
mouth: Sec. 3, Ch. 51
     after radiation therapy: Sec. 3, Ch. 51
pressure: (see Pressure sores)
Sotalol
in abnormal heart rhythms: Sec. 3, Ch. 47
in atrial flutter and fibrillation: Sec. 3, Ch. 47
in ventricular tachycardia: Sec. 3, Ch. 47
Sounds
perception of: Sec. 1, Ch. 2 (see also Hearing)
Spasmodic dysphonia: Sec. 3, Ch. 30
Spasmodic torticollis: Sec. 3, Ch. 30
Spasms
coronary artery: Sec. 3, Ch. 45
diaphragm (hiccups): Sec. 3 Ch. 30 [sidebar]
esophagus: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
leg
     during sleep: Sec. 3, Ch. 31
muscle: Sec. 3, Ch. 30
     treatment of: Sec. 2, Ch. 13
neck: Sec. 3, Ch. 30
upper eyelid (blepharospasm): Sec. 3, Ch. 30; Sec. 3, Ch. 36
vocal cord (dysphonia): Sec. 3, Ch. 30
Specificity
of test: Sec. 2, Ch. 10
Speech discrimination testing: Sec. 3, Ch. 37
Speech reading: Sec. 3, Ch. 37
Speech therapist: Sec. 2, Ch. 9
Speech threshold audiometry: Sec. 3, Ch. 37
Speech
after stroke: Sec. 2, Ch. 13
in stroke: Sec. 3, Ch. 28
therapy for: Sec. 2, Ch. 13; Sec. 2, Ch. 13
in vocal cord atrophy: Sec. 3, Ch. 38
loss of
     physician-patient communication and: Sec. 2, Ch. 8
perception of: Sec. 1, Ch. 2
     hearing loss and: Sec. 3, Ch. 37
in spasmodic dysphonia: Sec. 3, Ch. 30
Sphincter
esophageal: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
     botulinum toxin injection of: Sec. 3, Ch. 54
     cutting of: Sec. 3, Ch. 54
     in gastroesophageal reflux: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
urinary: Sec. 1, Ch. 2; Sec. 3, Ch. 57
Spider veins: Sec. 3, Ch. 44
Spinal cord
aging of: Sec. 1, Ch. 2
in compression fracture: Sec. 3, Ch. 23
inflammation of (transverse myelitis): Sec. 3, Ch. 52; Sec. 3, Ch. 52
pacemaker in
     in urge incontinence: Sec. 3, Ch. 57
Spinal nerves
in compression fracture: Sec. 3, Ch. 23
Spinal tap: Sec. 3, Ch. 28
Spine
compression fracture of: Sec. 3, Ch. 22
osteoporosis of: Sec. 3, Ch. 22
Spinning (dizziness): Sec. 3, Ch. 20
Spirituality: Sec. 4, Ch. 61
Spironolactone: Sec. 3, Ch. 18
in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46
high potassium levels with: Sec. 3, Ch. 18
Spleen
in myelofibrosis: Sec. 3, Ch. 49
in polycythemia vera: Sec. 3, Ch. 49
in thrombocythemia: Sec. 3, Ch. 49
removal of (splenectomy): Sec. 3, Ch. 49
Splenectomy: Sec. 3, Ch. 49
Splint: Sec. 3, Ch. 23
in osteoarthritis: Sec. 3, Ch. 41
Spondylosis
cervical
     dizziness in: Sec. 3, Ch. 20
Spouse
death of: Sec. 4, Ch. 61
Spur
heel: Sec. 3, Ch. 40
Sputum
in chronic bronchitis: Sec. 3, Ch. 53
in COPD: Sec. 3, Ch. 53; Sec. 3, Ch. 53
in influenza: Sec. 3, Ch. 52
in pneumonia: Sec. 3, Ch. 52; Sec. 3, Ch. 52
Squamous cell cancer: Sec. 3, Ch. 51
Squamous hyperplasia
of vulva: Sec. 3, Ch. 58
SREMs (selective estrogen receptor modifiers): Sec. 3, Ch. 22
SSRIs (selective serotonin reuptake inhibitors)
in anxiety: Sec. 3, Ch. 32
in depression: Sec. 3, Ch. 32
St. John's wort interaction with: Sec. 2, Ch. 7
undernutrition and: Sec. 3 Ch. 17 [detail]
St. John's wort: Sec. 2, Ch. 7; Sec. 2, Ch. 7
Staging
breast cancer: Sec. 3, Ch. 51
cancer: Sec. 3, Ch. 50
chronic lymphocytic leukemia: Sec. 3, Ch. 51
colorectal cancer: Sec. 3, Ch. 51
prostate cancer: Sec. 3, Ch. 51
Stairs
walking on: Sec. 2, Ch. 13
Staphylococcus aureus infection: Sec. 3, Ch. 52
Statins: Sec. 3, Ch. 44
in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45
after heart attack: Sec. 3, Ch. 45
Steakhouse syndrome: Sec. 3, Ch. 54
Stem cells: Sec. 3, Ch. 49; Sec. 3 Ch. 49 [sidebar]
transplantation of
     in chronic lymphocytic leukemia: Sec. 3, Ch. 51
     in multiple myeloma: Sec. 3, Ch. 51
     in myelofibrosis: Sec. 3, Ch. 49
Stenosis
aortic valve: Sec. 3, Ch. 48; Sec. 3 Ch. 46 [detail]
mitral valve: Sec. 3, Ch. 48; Sec. 3, Ch. 48
Stents
for heart attack: Sec. 3, Ch. 45
Steroids: (see also Corticosteroids)
anabolic
     medicinal herb interactions with: Sec. 2, Ch. 7
Stiffness
in polymyalgia rheumatica: Sec. 3, Ch. 42
Stimulant agents
in constipation: Sec. 3, Ch. 55; Sec. 3, Ch. 55
Stockings
in chronic venous insufficiency: Sec. 3, Ch. 44
in varicose veins: Sec. 3, Ch. 44
in deep vein thrombosis: Sec. 3, Ch. 44
after stroke: Sec. 3, Ch. 28
in edema: Sec. 3, Ch. 18
in heart failure: Sec. 3, Ch. 46
in low blood pressure: Sec. 3, Ch. 20
Stomach
acid in: (see Acid, stomach)
hernia of (hiatal hernia): Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
Stones
kidney: Sec. 3, Ch. 41; Sec. 3, Ch. 41; Sec. 3, Ch. 41; Sec. 3, Ch. 41
Stool (feces)
blood in: Sec. 3, Ch. 49
     in gastroesophageal reflux: Sec. 3, Ch. 54
in constipation: (see Constipation)
in diarrhea: (see Diarrhea)
examination of: Sec. 3, Ch. 55
impaction of: Sec. 3, Ch. 55; Sec. 3, Ch. 55
passing of: (see Bowel movements)
Stool softeners: Sec. 3, Ch. 55; Sec. 3, Ch. 55; Sec. 3, Ch. 55
in prostatitis: Sec. 3, Ch. 59
Stool
incontinence of
     in colorectal cancer: Sec. 3, Ch. 51
     during hospitalization: Sec. 2, Ch. 11
     pressure sores and: Sec. 3, Ch. 35
Stratum corneum: Sec. 3 Ch. 35 [detail]
Strengthening exercise: Sec. 1, Ch. 2; Sec. 2, Ch. 13; Sec. 3, Ch. 60
in arthritis: Sec. 3, Ch. 60
in Parkinson's disease: Sec. 3, Ch. 60
after stroke: Sec. 3, Ch. 60
Strep throat: Sec. 3, Ch. 48; Sec. 3, Ch. 48
Streptokinase: Sec. 3 Ch. 49 [sidebar]
in coronary artery disease: Sec. 3, Ch. 45
in deep vein thrombosis: Sec. 3, Ch. 44
in peripheral arterial disease: Sec. 3, Ch. 44
Stress incontinence: Sec. 3, Ch. 57; Sec. 3, Ch. 57
Stress testing: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 60
in ventricular tachycardia: Sec. 3, Ch. 47
Stress
abnormal heart rhythms: Sec. 3, Ch. 47
Stretching exercise: Sec. 3, Ch. 60
in arthritis: Sec. 3, Ch. 60
in Parkinson's disease: Sec. 3, Ch. 60
Stricture
esophageal: Sec. 3, Ch. 54; Sec. 3, Ch. 54
urethral
Stroke: Sec. 3, Ch. 44; Sec. 3, Ch. 28
in abnormal heart rhythms: Sec. 3, Ch. 47
atherosclerosis and: Sec. 3, Ch. 44
dementia after: Sec. 3, Ch. 27
in diabetes: Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3, Ch. 34
dizziness with: Sec. 3, Ch. 20
driving and: Sec. 4, Ch. 62
erectile dysfunction and: Sec. 3 Ch. 59 [detail]
exercise after: Sec. 3, Ch. 60
hemorrhagic: Sec. 3 Ch. 28 [detail]; Sec. 3, Ch. 28; Sec. 3, Ch. 28; Sec. 3, Ch. 28
in high blood pressure: Sec. 3, Ch. 43
information resources on: 883, 884
ischemic: Sec. 3 Ch. 28 [detail]; Sec. 3, Ch. 28; Sec. 3, Ch. 28
occipital lobe: Sec. 3, Ch. 36
prevention of: Sec. 3, Ch. 28
rehabilitation after: Sec. 2, Ch. 13; Sec. 3, Ch. 28
risk factors for: Sec. 3, Ch. 28
swallowing difficulty in: Sec. 3, Ch. 54
symptoms of: Sec. 3, Ch. 28
Stye: Sec. 3, Ch. 36
Subarachnoid hemorrhage: Sec. 3 Ch. 28 [detail]; Sec. 3, Ch. 28; Sec. 3, Ch. 28
Subdural bleeding (hematoma, hemorrhage)
dementia with: Sec. 3 Ch. 27 [sidebar]
Sugar(s)
blood
     high: (see Diabetes mellitus)
     low: (see Hypoglycemia)
     monitoring of: Sec. 3, Ch. 34
     screening of: Sec. 3, Ch. 34
urine: Sec. 3, Ch. 34
Suicide: Sec. 3 Ch. 32 [sidebar]
assisted: Sec. 2, Ch. 16
information resources on: 888
Sulfasalazine: Sec. 3, Ch. 41
Sulfinpyrazone: Sec. 3, Ch. 41; Sec. 3, Ch. 41
Sulfonylureas: Sec. 3, Ch. 34; Sec. 3, Ch. 34
Sun-downing: Sec. 3, Ch. 31
Sunlight
exposure to: Sec. 1, Ch. 2
Superficial thrombophlebitis: Sec. 3, Ch. 44
Supplemental health care insurance: Sec. 4, Ch. 66
Supplements
dietary: Sec. 1, Ch. 1; Sec. 2, Ch. 7
     drug interactions with: Sec. 2, Ch. 6; Sec. 2, Ch. 7; Sec. 2, Ch. 7
     for nutritional disorders: Sec. 3, Ch. 17
enzyme: Sec. 2, Ch. 7
hormone: Sec. 2, Ch. 7; Sec. 3, Ch. 59; Sec. 1 Ch. 1 [sidebar]; Sec. 3 Ch. 59 [sidebar]
mineral
     medicinal herb interactions with: Sec. 2, Ch. 7
Support stockings
in edema: Sec. 3, Ch. 18
in heart failure: Sec. 3, Ch. 46
in low blood pressure: Sec. 3, Ch. 20
Supranuclear palsy
progressive: Sec. 3, Ch. 30
Supraventricular tachycardia: Sec. 3, Ch. 47
Surgeon: Sec. 2, Ch. 9
Surgery: Sec. 2, Ch. 12
in abnormal heart rhythms: Sec. 3, Ch. 47
anesthesia for: Sec. 2, Ch. 12
aortic aneurysm: Sec. 3, Ch. 44
aortic dissection: Sec. 3, Ch. 44
aortic stenosis: Sec. 3, Ch. 48
benign prostatic hyperplasia: Sec. 3, Ch. 59
in breast cancer: Sec. 3, Ch. 51
cancer: Sec. 3, Ch. 50
care after: Sec. 2, Ch. 12; Sec. 2, Ch. 12
colorectal cancer: Sec. 3, Ch. 51
complications of: Sec. 2, Ch. 12
coronary artery disease: Sec. 3, Ch. 45; Sec. 3 Ch. 48 [sidebar]
eye: Sec. 3 Ch. 36 [sidebar]
     in cataracts: Sec. 3, Ch. 36
     in diabetic retinopathy: Sec. 3, Ch. 36
     in glaucoma: Sec. 3, Ch. 36
in fainting-related disorder: Sec. 3, Ch. 20
fracture: Sec. 3, Ch. 23
hammer toe: Sec. 3, Ch. 40
heart: Sec. 3 Ch. 48 [sidebar]
     in abnormal heart rhythms: Sec. 3, Ch. 47
     in coronary artery disease: Sec. 3, Ch. 45
     in heart failure: Sec. 3, Ch. 46
     in heart valve disorders: Sec. 3, Ch. 48; Sec. 3, Ch. 48; Sec. 3 Ch. 48 [sidebar]; Sec. 3, Ch. 48
     rehabilitation after: Sec. 2, Ch. 13
hip
     for fracture: Sec. 3, Ch. 23
     in osteoarthritis: Sec. 3, Ch. 41
     rehabilitation after: Sec. 2, Ch. 13
     in rheumatoid arthritis: Sec. 3, Ch. 41
informed consent for: Sec. 4, Ch. 65
inguinal hernia: Sec. 3, Ch. 59
knee: Sec. 3, Ch. 41
     in osteoarthritis: Sec. 3, Ch. 41
     in rheumatoid arthritis: Sec. 3, Ch. 41
leg amputation: Sec. 3, Ch. 44; Sec. 2, Ch. 13
long-term care facility after: Sec. 2, Ch. 14
lung cancer: Sec. 3, Ch. 51
monitoring during: Sec. 2, Ch. 12
in pelvic support disorders: Sec. 3, Ch. 58
positioning for: Sec. 2, Ch. 12
preparation for: Sec. 2, Ch. 12
prostate cancer: Sec. 3, Ch. 51; Sec. 3, Ch. 51
in stress incontinence: Sec. 3, Ch. 57
urinary incontinence and: Sec. 3, Ch. 57
in urinary tract infection: Sec. 3, Ch. 56
varicose vein: Sec. 3, Ch. 44
in ventricular tachycardia: Sec. 3, Ch. 47
vocal cord: Sec. 3, Ch. 38
vulvar cancer: Sec. 3, Ch. 51
Surrogate: Sec. 4, Ch. 65
Suspiciousness (paranoia): Sec. 3, Ch. 32
Swallowing: Sec. 3, Ch. 54
aging-related changes in: Sec. 3, Ch. 54
abnormal heart rhythms with: Sec. 3, Ch. 47
difficulty in: Sec. 3, Ch. 54
     acid reflux and: Sec. 3, Ch. 54
disorders of: Sec. 3, Ch. 38; Sec. 3, Ch. 54; Sec. 3, Ch. 54
in Parkinson's disease: Sec. 3, Ch. 30
in progressive supranuclear palsy: Sec. 3, Ch. 30
therapy for: Sec. 2, Ch. 13
Sweat glands: Sec. 1, Ch. 2
Sweating: Sec. 3 Ch. 19 [detail]
Swelling (edema): Sec. 3, Ch. 18
in deep vein thrombosis: Sec. 3, Ch. 44
with fracture: Sec. 3, Ch. 23
in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46; Sec. 3, Ch. 46; Sec. 3, Ch. 46
horse chestnut in: Sec. 2, Ch. 7
pulmonary: (see Pulmonary edema)
Swimming pool
exercise in: Sec. 3, Ch. 60; Sec. 3, Ch. 60; Sec. 3, Ch. 60
Swimming: Sec. 2, Ch. 13
ear blockages with: Sec. 3, Ch. 37
Syncope: (see Fainting)
Syphilis
dementia with: Sec. 3 Ch. 27 [sidebar]
Systemic sclerosis: Sec. 3, Ch. 54
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.